Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/30/26 16:05 | 6/26/26 | VCEL | Health | BioPrd | Biological Products, (No Diag | Siegal Jonathan | MA | O | Principa | 2 | S.dm | -311 | 40.95 | 0 | -8 | 1 | D | |||||||||||||||
6/30/26 16:05 | 6/26/26 | VCEL | Health | BioPrd | Biological Products, (No Diag | Mara Joseph Anthony Jr | MA | O | CFO | 2 | S | -426 | 42.63 | 0 | -10 | 21 | D | |||||||||||||||
6/30/26 16:05 | 6/26/26 | VCEL | Health | BioPrd | Biological Products, (No Diag | Hopper Jonathan Mark | MA | O | Chief Me | 2 | S.d | -603 | 41.96 | 0 | -14 | 76 | D | |||||||||||||||
6/30/26 16:05 | 6/26/26 | VCEL | Health | BioPrd | Biological Products, (No Diag | Flynn Sean C. | MA | O | GC | 2 | S.d | -1,288 | 42.93 | 0 | -30 | 2 | D | |||||||||||||||
6/22/26 16:05 | 6/18/26 | VCEL | Health | BioPrd | Biological Products, (No Diag | Halpin Michael | MA | O | COO | 1 | S.d | -402 | 40.24 | 0 | -10 | 16 | D | |||||||||||||||
5/15/26 16:06 | 5/13/26 | VCEL | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | D | 1 | S.d | -230 | 32.83 | 0 | -7 | 18 | D | ||||||||||||||||
5/13/26 16:05 | 5/11/26 | VCEL | Health | BioPrd | Biological Products, (No Diag | Wotton Paul K | MA | D | 1 | S | -327 | 32.74 | 0 | -10 | 19 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |